Core Cap Advisors, LLC Anixa Biosciences Inc Transaction History
Core Cap Advisors, LLC
- $2.64 Billion
- Q3 2025
A detailed history of Core Cap Advisors, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Core Cap Advisors, LLC holds 46,787 shares of ANIX stock, worth $192,762. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,787
Previous 46,787
-0.0%
Holding current value
$192,762
Previous $154,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding ANIX
# of Institutions
71Shares Held
5.32MCall Options Held
14.1KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA1.42MShares$5.86 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC617KShares$2.54 Million0.28% of portfolio
-
D.A. Davidson & Co.614KShares$2.53 Million0.01% of portfolio
-
Ubs Group Ag505KShares$2.08 Million0.0% of portfolio
-
Mission Wealth Management, LP356KShares$1.47 Million0.02% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $126M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...